Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease

Autor: Wolfe, Rory, Wetmore, James B., Woods, Robyn L., McNeil, John J., Gallagher, Hugh, Roderick, Paul, Walker, Rowan, Nelson, Mark R., Reid, Christopher M., Shah, Raj C., Ernst, Michael E., Lockery, Jessica E., Tonkin, Andrew M., Abhayaratna, Walter P., Gibbs, Peter, Wood, Erica M., Mahady, Suzanne E., Williamson, Jeff D., Donnan, Geoffrey A., Cloud, Geoffrey C., Murray, Anne M., Polkinghorne, Kevan R.
Zdroj: In Kidney International February 2021 99(2):466-474
Databáze: ScienceDirect